​

uniQure (QURE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

QURE Stock Forecast

uniQure (QURE) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $24.00, with a high of $24.00 and a low of $24.00. This represents a 57.48% increase from the last price of $15.24.

- $5 $10 $15 $20 $25 High: $24 Avg: $24 Low: $24 Last Closed Price: $15.24

QURE Stock Rating

uniQure stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 7 Strong Sell Sell Hold Buy Strong Buy

QURE Forecast vs Benchmarks

TypeNameUpside
StockuniQure57.48%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$24.00$24.00$24.00
Last Closing Price$15.24$15.24$15.24
Upside/Downside57.48%57.48%57.48%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25282--12
Dec, 24393--15
Nov, 24373--13
Oct, 24474--15
Sep, 24474--15
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 07, 2025Luca IssiRBC Capital$24.00$17.6436.05%57.48%
Nov 23, 2022Goldman Sachs$57.00$25.38124.59%274.02%
Aug 08, 2022Matthew BarcusChardan Capital$60.00$18.64221.89%293.70%
May 03, 2022Credit Suisse$51.00$15.85221.77%234.65%
Jan 07, 2022Yanan ZhuWells Fargo$34.00$19.5074.36%123.10%
Dec 16, 2021Danielle BrillRaymond James$58.00$20.24186.56%280.58%
Oct 28, 2021Suji JeongJefferies$62.00$30.65102.28%306.82%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 07, 2025RBC CapitalOutperformOutperformhold
Jul 09, 2024GuggenheimBuyBuyhold
Mar 04, 2024Cowen & Co.NeutralNeutralhold
Jun 22, 2023Chardan CapitalBuyBuyhold
Feb 28, 2023Credit SuisseOutperformOutperformhold
Dec 29, 2022H.C. WainwrightBuyBuyhold
Nov 23, 2022Goldman SachsBuyBuyhold
May 03, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-15 $-8 $-1 $6 $13 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.81$7.17$-2.71$-0.01-----
Avg Forecast$-3.65$6.17$-3.75$-6.31$-4.08$-3.38$-2.65$0.24$1.59
High Forecast$-11.33$0.81$-12.82$-6.79$-4.81$-4.08$-3.47$-1.77$0.02
Low Forecast$-0.48$19.18$-0.76$-5.52$-2.60$-2.04$-1.18$0.94$4.29
Surprise %-23.01%16.21%-27.73%-99.84%-----

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$37.51M$524.00M$106.48M$15.84M-----
Avg Forecast$116.44M$475.82M$30.57M$20.88M$41.03M$35.04M$115.19M$224.16M$426.50M
High Forecast$38.57M$157.60M$11.85M$17.22M$16.50M$8.45M$27.78M$217.44M$102.84M
Low Forecast$305.28M$1.25B$87.54M$24.70M$87.71M$80.89M$265.96M$230.88M$984.69M
Surprise %-67.78%10.13%248.31%-24.11%-----

Net Income Forecast

$-550M $-360M $-170M $20M $210M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-125.02M$329.59M$-126.79M$-308.48M-----
Avg Forecast$-173.76M$278.41M$-158.89M$-308.48M$-176.70M$-157.36M$-121.56M$-54.56M$75.77M
High Forecast$-540.09M$169.98M$-196.81M$-382.09M$-229.37M$-194.66M$-165.31M$-84.60M$1.02M
Low Forecast$-22.69M$386.84M$-120.98M$-234.86M$-124.03M$-97.07M$-56.14M$44.92M$204.69M
Surprise %-28.05%18.38%-20.20%------

QURE Forecast FAQ

Is uniQure stock a buy?

uniQure stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that uniQure is a favorable investment for most analysts.

What is uniQure's price target?

uniQure's price target, set by 8 Wall Street analysts, averages $24 over the next 12 months. The price target range spans from $24 at the low end to $24 at the high end, suggesting a potential 57.48% change from the previous close price of $15.24.

How does uniQure stock forecast compare to the average forecast of its sector, industry, and investment themes?

uniQure stock forecast shows a 57.48% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for uniQure over the past three months?

  • January 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 23.08% Strong Buy, 53.85% Buy, 23.08% Hold, 0% Sell, 0% Strong Sell.

What is uniQure’s EPS forecast?

uniQure's average annual EPS forecast for its fiscal year ending in December is -4.08 for 2024, a 40700.00% increase from the reported $-0.01 in 2023. The prediction for 2025 is $-3.38, $-2.65 for 2026, $0.24 for 2027, and $1.59 for 2028.

What is uniQure’s revenue forecast?

uniQure's average annual revenue forecast for its fiscal year ending in December is $41.03M for 2024, a 159.00% increase from the reported $15.84M in 2023. The forecast for 2025 is $35.04M, $115.19M for 2026, $224.16M for 2027, and $426.5M for 2028.

What is uniQure’s net income forecast?

For its fiscal year ending in December, uniQure's average annual net income forecast is $-177M for 2024, reflecting a -42.72% decrease from the reported $-308M in 2023. The projection for 2025 is $-157M, $-122M for 2026, $-54.563M for 2027, and $75.77M for 2028.